Practical management: Nonsteroidal antiinflammatory drug (NSAID) use in athletic injuries

Clinical Journal of Sport Medicine

Volumn 16, Issue 2, 2006, Pages 170-174

  Mehallo, Christopher J ^a   Drezner, Jonathan A ^b   Bytomski, Jeffrey R ^c  

^a McShane Sports Medicine   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

COX 2; Fracture; Injury; NSAID; Sprain; Strain; Tendinitis

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOROLAC; MECLOFENAMIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARECOXIB; PIROXICAM; ROFECOXIB; VALDECOXIB;

ANALGESIA; ARTICLE; BONE INJURY; CARDIOTOXICITY; CHRONIC MUSCLE INJURY; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ECCENTRIC MUSCLE INJURY; EVIDENCE BASED MEDICINE; FRACTURE; FRACTURE NONUNION; GASTROINTESTINAL SYMPTOM; HUMAN; LIGAMENT INJURY; MUSCLE INJURY; MUSCLE STRAIN; NEPHROTOXICITY; NONHUMAN; OSSIFYING MYOSITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT COURSE THERAPY; SPORT INJURY; STRESS FRACTURE; TENDINITIS; TREATMENT DURATION; WOUND HEALING IMPAIRMENT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATHLETIC INJURIES; FRACTURES, BONE; HUMANS; MYOSITIS OSSIFICANS; SPRAINS AND STRAINS; TENDINOPATHY;

EID: 33646369675     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042752-200603000-00015     Document Type: Article

References (43)

1. Samad TA, Sapirstein A, Woolf CJ. Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets. Trends Mol Med. 2002;8:390-396.
2. Kawaguchi H, Pilbeam CC, Harrison JR, et al. The role of prostaglandins in the regulation of bone metabolism. Clin Orthop. 1995;313:36-46.
3. Altman RD, Latta LL, Keer R, et al. Effect of nonsteroidal anti-inflammatory drugs on fracture healing: A laboratory study in rats. J Orthop Trauma. 1995;9:392-400.
4. Allen H, Wase A, Bear W. Indomethacin and aspirin: effect of nonsteroidal anti-inflammatory agents on the rate of fracture repair in the rat. Acta Orthop Scand. 1980;51:595-600.
5. Elves M, Bayley I, Roylance P. The effect of indomethacin upon experimental fractures in the rat. Acta Orthop Scand. 1982;53:35-41.
6. Dimar JR, Ante WA, Zhang YP, et al. The effects of nonsteroidal anti-inflammatory drugs on posterior spinal fusions in the rat. Spine. 1996;21:1870-1876.
7. Beck A, Krischak G, Sorg T, et al. Influence of diclofenac (group of nonsteroidal anti-inflammatory drugs) on fracture healing. Arch Orthop Trauma Surg. 2003;123:327-332.
8. Butcher CK, Marsh DR. Nonsteroidal anti-inflammatory drugs delay tibial fracture union. Injury. 1996;27:375.
9. Bhattacharyya T, Levin R, Vrahas MS, et al. Nonsteroidal anti-inflammatory drugs and nonunion of humeral shaft fractures. Arthritis Rheum. 2005;53:364-367.
10. Burd TA, Hughes MS, Anglen JO. Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion. J Bone Joint Surg [Br]. 2003;85-B:700-705.
11. Giannoudis PV, MacDonald DA, Matthews SJ, et al. Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J Bone Joint Surg [Br]. 2000;82-B:655-658.
12. Glassman SD, Rose SM, Dimar JR, et al. The effect of post-operative nonsteroidal anti-inflammatory drug administration on spinal fusion. Spine. 1998;23:834-838.
13. Reuben SS, Ablett D, Kaye R. High dose nonsteroidal anti-inflammatory drugs compromise spinal fusion. Can J Anaesth. 2005;52:506-512.
14. Reuben SS, Ekman EF. The effect of cyclooxygenase-2 inhibition on analgesia and spinal fusion. J Bone Joint Surg Am. 2005;87:536-542.
15. Radi ZA, Khan NK. Effects of cyclooxygenase inhibition on bone, tendon, and ligament healing. Inflamm Res. 2005;54:358-366.
16. Dahners LE, Gilbert JA, Lester GE, et al. The effect of a nonsteroidal anti-inflammatory drug on the healing of ligaments. Am J Sports Med. 1988;16:641-646.
17. Hanson CA, Weinhold PS, Afshari HM, et al. The effect of analgesic agents on the healing of rat medial collateral ligament. Am J Sports Med. 2005;33:674-679.
18. Elder CL, Dahners LE, Weinhold PS. A cyclooxygenase-2 inhibitor impairs ligament healing in the rat. Am J Sports Med. 2001;29:801-805.
19. Moorman CT, Kukreti U, Fenton DC, et al. The early effect of ibuprofen on the mechanical properties of healing medial collateral ligament. Am J Sports Med. 1999;27:738-741.
20. Moran M. An observer blind comparison of diclofenac potassium, piroxicam and placebo in the treatment ankle sprains. Curr Med Res Opin. 1990;12:268-274.
21. Moran M. Double-blind comparison of diclofenac potassium, ibuprofen and placebo in the treatment of ankle sprains. J Int Med Res. 1991;19:121-130.
22. Slatyer MA, Hensley MJ, Lopert R. A randomized controlled trial of piroxicam in the management of acute ankle sprain in Australian regular army recruits. The Kapooka ankle sprain study. Am J Sports Med. 1997;25:544-553.
23. Petrella R, Ekman EF, Schuller R, et al. Efficacy of celecoxib, a COX-2 inhibitor, and naproxen in the management of acute ankle sprain. Result of a double-blind, randomized controlled trial. Clin J Sport Med. 2004;14:225-231.
24. Jarvinen TAH, Jarvinen TLN, Kaariainen M, et al. Muscle injuries biology and treatment. Am J Sports Med. 2005;33:745-764.
25. Almekinders LC, Gilbert JA. Healing of experimental muscle strains and the effects of nonsteroidal anti-inflammatory medication. Am J Sports Med. 1986;14:303-308.
26. Obremsky WT, Seaber AV, Ribbeck BM, et al. Biomechanical and histologic assessment of a controlled muscle strain injury treated with piroxicam. Am J Sports Med. 1994;22:558-561.
27. Reynolds JF, Noakes TD, Schwellnus MP, et al. Non-steroidal anti-inflammatory drugs fail to enhance healing of acute hamstring injuries treated with physiotherapy. S Afr Med J. 1995;85:517-522.
28. Dudley GA, Czerkawski J, Meinrod A, et al. Efficacy of naproxen sodium for exercise-induced dysfunction muscle injury and soreness. Clin J Sport Med. 1997;7:3-10.
29. Baldwin AC, Stevenson SW, Dudley GA. Nonsteroidal anti-inflammatory therapy after eccentric exercise in healthy older individuals. J Gerontol A Biol Sci Med Sci. 2001;56:M510-M513.
30. Stone MB, Merrick MA, Ingersoll CD, Edwards JE. Preliminary comparison of bromelain and ibuprofen for delayed onset muscle soreness management. Clin J Sport Med. 2002;12:373-378.
31. Fijn R, Koorevaar RT, Brouwers RBJ. Prevention of heterotopic ossification after total hip replacement with NSAIDs. Pharm World Sci. 2003;25:138-145.
32. Romano CL, Duci D, Romano D, et al. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty. 2004;19:14-18.
33. Sharma P, Maffulli N. Tendon injury and tendinopathy: healing and repair. J Bone Joint Surg [Am]. 2005;87A:187-202.
34. Khan KM, Cook JL, Maffulli N, Kannus P. Where is the pain coming from in tendinopathy? It may be biochemical, not only structural, in origin. Br J Sports Med. 2000;34:81-83.
35. Astrom M, Westlin N. No effect of piroxicam on achilles tendinopathy. Acta Orthop Scand. 1992;63:631-634.
36. Lane LB, Boretz RS, Stuchin SA. Treatment of de Quervain's disease: role of conservative management. J Hand Surg [Br]. 2001;26:258-260.
37. Mamdani M, Rochon PA, Juurlink DN, et al. Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs. BMJ. 2002;325:624.
38. Curhan GC, Willett WC, Rosner B, et al. Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med. 2002;162:2204-2208.
39. Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ. 2005;330:1366.
40. Solomon SD, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005;352:1071-1080.
41. Graham DJ, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet. 2005;365:475-481.
42. Nussmeier NA, et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med. 2005;352:1081-1091.
43. Center for Drug Evaluation and Research, U.S. Food and Drug Administration. June 15, 2005. Available at: http://www.fda. gov/cder/drug/infopage/COX2/NSAIDmedguide.htm. Accessed December 27, 2005.